Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis

Kidney International

Volumn 54, Issue 4, 1998, Pages 1166-1174

  Suzuki, Yusuke ^b   Shirato, Isao ^b   Okumura, Ko ^b   Ravetch, Jeffrey V ^b   Takai, Toshiyuki ^b   Tomino, Yasuhiko ^b   Ra, Chisei ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b NONE

Author keywords

Angiotensin II; Anti GBM antibody induced glomerulonephritis; FcR chain; Fc RIIB; Immune complex; Monocyte macrophage; Polymorphonuclear cell

Indexed keywords

ANGIOTENSIN; FC RECEPTOR; GLOMERULUS BASEMENT MEMBRANE ANTIBODY;

ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; GLOMERULONEPHRITIS; INFLAMMATORY CELL; MACROPHAGE; MESANGIUM CELL; MONOCYTE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0031702690     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00108.x     Document Type: Article

References (36)

1. WILSON CB: Renal response to immunologic glomerular injury, in The Kidney (5th ed), edited by BRENNER BM, Philadelphia, WB Saunders, 1996, pp 1253-1391
2. LERNER R, GLASSOCK RJ, DIXON FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989-1004, 1967
3. RAVETCH JV: Fc receptors: Rubor redux. Cell 78:553-560, 1994
4. RA C, JOUVIN MH, BLANK U, KINET JP: A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit. Nature 341:752-754, 1989
5. TAKAI T, LI M, SYLVESTRE L, CLYNES R, RAVETCH JV: FcR γ chain depletion results in pleiotrophic effector cell defects. Cell 76:519-529, 1994
6. DAERON M, MALBEC O, LATOUR S, AROCK M, FRIDMAN WH: Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptor. J Clin Invest 95:577-585, 1995
7. POOLE A, GIBBINS JM, TURNER M, VAN VUGT MJ, VAN DE WINKEL, JGJ, SAITO T, TYBULEWICZ VLJ, WATSON SH: The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16:2333-2341, 1997
8. TAKAI T, ONO M, HIKIDA M, OHMORI H, RAVETCH JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346-349, 1996
9. KNIGHT JG, ADAMS DD, PURVES HD: The genetic contribution of the NZB mouse to the renal disease of the NZBNZW hybrid. Clin Exp Immunol 28:352-358, 1977
10. SCHÜRCH W, SKALLI O, SEFMAYER TA, GABBIANI G: Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol 128:91-103, 1987
11. ALPERS CE, HUDKINS KL, GOWN AM, JOHNSON R: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41:1134-1142, 1992
12. ASSMAN KJM, TANGELDER MM, LANGE WPJ, SCHRIJVER G, KOENE RAP: Anti-GBM nephritis in the mouse: Severe proteinuria in the heterologous phase. Virchow Arch A 406:285-300, 1985
13. DAVIS SW, HAMMERBERG B: Taenia Taeniaeformis: Evasion of complement-mediated lysis by early larval stages following activation of the alternative pathway. Int J Parasitol 20:587-593, 1990
14. LIU Z, GIUDICE GJ, SWARTZ SJ, FAIRLEY JA, TILL GO, TROY JL, DIAZ LA: The role of complement in experimental bullous pemphigoid. J Clin Invest 45:1539-1544, 1995
15. PIMM MV, GRIBBEN SJ: Toxicity associated with formation and clearance of immune complexes between antitumour monoclonal antibodies and syngenetic anti-idiotypic antibodies in mice. J Cancer Res Clin Oncol 119:41-45, 1992
16. SHIBOUTA Y, CHATANI F, ISHIMURA Y, SANADA T, OHTA M, INADA Y, NISHIKAWA K: TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats. Kidney Int 49(Suppl 55):S115-S118, 1996
17. FURUKAWA Y, MATSUMORI A, HIROZANE T, SASAYAMA S: Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 93:333-339, 1996
18. SYLVESTRE DL, RAVETCH JV: Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 265:1095-1098, 1994
19. WILSON CB: Immune models of glomerular injury, in Immunologic Renal Diseases, edited by NIELSON EG, COUSER WG. Philadelphia, Lippincott-Raven Publishers, 1997, pp 729-773
20. BOYCE NW, HOLDWORTH SR: Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: Evidence for a dose-dependent direct antibody and complement-induced, cell-independent injury. J Immunol 135:3918-3921, 1985
21. PAWANKAR R, OKUDA M, YSSEL H, OKUMURA K, RA C: Nasal mast cell in perennial allergic rhinitis exhibit increased expression of the Fc∈RI, CD40L, IL-4, IL-13, and can induce IgE synthesis in B cells. J Clin Invest 99:1492-1499, 1997
22. HORA K, SATRIANO JA, SANTIAGO A, MORI T, STANLEY ER, SHAN Z, SCHLONDORFF D: Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89:1745-1749, 1992
23. GÓMEZ-GUERRERO C, GONZÁLEZ E, EGIDO J: Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 151:7171-7181, 1993
24. RADEKE HH, GESSNER JE, UCIECHOWSKI P, MÄGERT H-J, SCHMIDT RE, RESCH K: Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFcγRIII-A) and the associated Fc∈RI γ-chain. J Immunol 153:1281-1292, 1994
25. ICHIKAWA I, HARRICE RC: Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40:583-596, 1991
26. ARAI M, WADA A, ISAKA Y, AKAGI Y, SUGIURA T, MIYAZAKI M, MORIYAMA T, KANEDA Y, NARUSE K, NARUSE M, ORITA Y, ANDO A, KAMADA T, UEDA N, IMAI E: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 206:525-532, 1995
27. LEE LK, MEYER TW, POLLOCK AS, LOVETT DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964, 1995
28. KLAHL S, SCREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1665, 1988
29. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progression renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
30. SUGAYA T, NISHIMURA S, TANIMOTO K, TAKIMOTO E, YAMAGISHI T, IMAMURA K, GOTO S, IMATZUMI K, HISADA Y, OTSUKA A, UCHIDA H, SUGIURA M, FUKUTA K, FUKAMIZU A, MURAKAMI K: Angiotensin II type 1 a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722, 1995
31. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107 1992
32. BAKRIS GL, RE RN: Endotherin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 264:F937-F942, 1993
33. GÓMEZ-GARRE D, RUIZ-ORTEGA M, ORTEGA M, LARGO R, LÓPEZ-ARMADA MJ, PLAZA JJ, GONZÁLEZ E, EGIDO J: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885-892, 1996
34. SINGHAL PC, SANTIAGO A, SATRIANO R, HAYS RM, SCHLONDORFF D: Effects of vasoactive agents on uptake of immunoglobulin G complexes by mesangial cells. Am J Physiol 258:F589-F596, 1990
35. BOYCE NW, HOLDWORTH SR: Intrarenal hemodynamic alterations induced by anti-GBM antibody. Kidney Int 31:8-14, 1987
36. TIMMERMANS V, PEAKE PW, CHARLESWORTH JA, MACDONALD GJ, PAWLAK MA: Angiotensin II receptor regulation in anti-glomerular basement membrane nephritis. Kidney Int 38:518-524, 1990